Retirement Capital Strategies’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-2,390
Closed -$215K – 61
2022
Q2
$215K Hold
2,390
– – 0.1% 55
2022
Q1
$264K Hold
2,390
– – 0.11% 50
2021
Q4
$247K Hold
2,390
– – 0.09% 70
2021
Q3
$300K Hold
2,390
– – 0.12% 61
2021
Q2
$297K Hold
2,390
– – 0.11% 71
2021
Q1
$282K Hold
2,390
– – 0.11% 68
2020
Q4
$280K Hold
2,390
– – 0.11% 59
2020
Q3
$240K Hold
2,390
– – 0.11% 56
2020
Q2
$219K Hold
2,390
– – 0.1% 42
2020
Q1
$216K Hold
2,390
– – 0.12% 36
2019
Q4
$271K Hold
2,390
– – 0.13% 44
2019
Q3
$260K Hold
2,390
– – 0.13% 44
2019
Q2
$233K Hold
2,390
– – 0.12% 46
2019
Q1
$218K Hold
2,390
– – 0.11% 45
2018
Q4
$217K Hold
2,390
– – 0.12% 43
2018
Q3
$235K Hold
2,390
– – 0.12% 40
2018
Q2
$205K Buy
+2,390
New +$200K 0.11% 29

Other funds holding MDT

Retirement Capital Strategies's MDT Position: Q3 2022 in Review

Retirement Capital Strategies sold out of Medtronic (MDT) in Q3 2022, closing a stake of 2,390 shares — an estimated $215K sold.

Retirement Capital Strategies first reported a position in MDT in Q2 2018 and held it in 17 quarters. The position peaked at $300K in Q3 2021. 1,931 funds tracked by Wall St. Rank hold MDT as of Q3 2022.

  • Retirement Capital Strategies reported no remaining Medtronic position as of Q3 2022 after selling out during the quarter.
  • Retirement Capital Strategies sold 2,390 Medtronic shares in Q3 2022, an estimated $215K.
  • Retirement Capital Strategies first reported a position in Medtronic in Q2 2018 and held it in 17 quarters.
  • Retirement Capital Strategies's Medtronic position peaked at $300K in Q3 2021.
  • 1,931 funds tracked by Wall St. Rank held Medtronic as of Q3 2022.

Based on Retirement Capital Strategies's 13F filing for Q3 2022, filed 10 Nov 2022.